World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
62
Citations
12638
World Ranking
2986
National Ranking
12

Overview

Raymond L. Stallings is affiliated with the Royal College of Surgeons in Ireland. Their research primarily spans the domains of Medicine and Biochemistry, Genetics, and Molecular Biology, with notable contributions across related subfields including Molecular Biology, Neurology, Surgery, Cell Biology, and Pulmonary and Respiratory Medicine.

The scientist's work has concentrated significantly on Neuroblastoma Research and Treatments, addressing various biological processes relevant to clinical oncology. Additional main topics of study include Signaling Pathways in Disease, Mechanisms of Cancer Metastasis, Polyamine Metabolism and Applications, Pancreatic Function and Diabetes, Cellular Mechanics and Interactions, and Sarcoma Diagnosis and Treatment.

Recent publications highlight an interest in molecular and cellular mechanisms underpinning cancer and disease progression. Noteworthy papers include:

  • "A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro" (2020) published in Frontiers in Cell and Developmental Biology
  • "A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma" (2021) published in Cancers
  • "Correction: Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators" (2023) published in PLoS ONE

These publications reflect the integration of molecular biology techniques with clinical oncology topics, particularly focusing on genetic and cellular factors influencing neuroblastoma and cancer metastasis.

Stallings frequently collaborates with a number of coauthors. Regular collaborators include:

  • Olga Piskareva
  • Ellen King
  • Nadiya Bayeva
  • John Nolan
  • Manuela Salvucci

The venues in which Stallings has published are specialized journals featuring molecular and cellular biology, oncology, and clinical research. These include Frontiers in Cell and Developmental Biology, Cancers, and PLoS ONE.

Best Publications

  • MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

    C Welch;Y Chen;R L Stallings

  • Evolution and distribution of (GT)n repetitive sequences in mammalian genomes

    R.L. Stallings;A.F. Ford;D. Nelson;D.C. Torney

  • Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects

    Eva M Jimenez-Mateos;Tobias Engel;Paula Merino-Serrais;Ross C McKiernan

  • Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis

    Yongxin Chen;Raymond L. Stallings

  • LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

    Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner

  • Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH

    Rebecca R. Selzer;Todd A. Richmond;Nathan J. Pofahl;Roland D. Green

  • Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.

    Erin L. Heinzen;Rodney A. Radtke;Thomas J. Urban;Gianpiero L. Cavalleri

  • Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

    Amanda Tivnan;Amanda Tivnan;Wayne Shannon Orr;Wayne Shannon Orr;Vladimir Gubala;Robert Nooney

  • Human metallothionein genes: structure of the functional locus at 16q13.

    A.K. West;R. Stallings;C.E. Hildebrand;R. Chiu

  • miRNA Expression Profile after Status Epilepticus and Hippocampal Neuroprotection by Targeting miR-132

    Eva M. Jimenez-Mateos;Isabella Bray;Amaya Sanz-Rodriguez;Tobias Engel

  • miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression

    Irene K. Oglesby;Isabella M. Bray;Sanjay H. Chotirmall;Raymond L. Stallings

  • Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma

    Jo Vandesompele;Michael Baudis;Katleen De Preter;Nadine Van Roy

  • Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

    Katleen De Preter;Jo Vandesompele;Pierre Heimann;Nurten Yigit

  • The sequence and analysis of duplication-rich human chromosome 16

    Joel Martin;Cliff Han;Laurie A. Gordon;Astrid Terry

  • Physical mapping of human chromosomes by repetitive sequence fingerprinting.

    Raymond L. Stallings;David C. Torney;Carl E. Hildebrand;Jonathan L. Longmire

  • Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy

    Suzanne F.C. Miller-Delaney;Kenneth Bryan;Sudipto Das;Ross C. McKiernan

  • MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.

    Niamh H. Foley;Niamh H. Foley;Isabella M. Bray;Isabella M. Bray;Amanda Tivnan;Amanda Tivnan;Kenneth Bryan;Kenneth Bryan

  • MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway

    Jennifer Lynch;Joanna Fay;Joanna Fay;Maria Meehan;Maria Meehan;Kenneth Bryan;Kenneth Bryan

  • MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.

    N H Foley;I Bray;I Bray;K M Watters;K M Watters;S Das;S Das

  • MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

    Amanda Tivnan;Amanda Tivnan;Lorraine Tracey;Patrick G Buckley;Patrick G Buckley;Leah C Alcock;Leah C Alcock

Frequent Co-Authors

Jo Vandesompele
Jo Vandesompele Ghent University
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin
Katleen De Preter
Katleen De Preter Ghent University
Rogier Versteeg
Rogier Versteeg University of Amsterdam
Michael J. Siciliano
Michael J. Siciliano The University of Texas MD Anderson Cancer Center
Norman A. Doggett
Norman A. Doggett Los Alamos National Laboratory
David F. Callen
David F. Callen University of Adelaide
Franki Speleman
Franki Speleman Ghent University
Jan Koster
Jan Koster University of Amsterdam
Genevieve Laureys
Genevieve Laureys Ghent University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics can open doors to diverse careers within healthcare and research. A strong foundation in genetics often complements allied health professions, many of which now offer flexible and affordable online pathways.

For those interested in direct patient care, you may consider shortest lpn program options for a faster entry into healthcare. Alternatively, students who wish to bypass standardized testing can look into nursing schools that don't require teas, creating additional accessibility.

Looking to move into healthcare management? Pursuing one of the cheapest mha programs online healthcare can pave the way towards leadership roles in hospital or laboratory settings. For advanced practice or research, check out the cheapest online nursing phd programs for doctoral studies.

These options allow genetics students to tailor their educational journey—aligning career goals with flexible, affordable online learning opportunities.

Best Scientists Citing Raymond L. Stallings

Trending Scientists